IRVINE, Calif., May 31, 2023 — Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on the development and commercialization of therapies for patients with rare genetic mitochondrial diseases, today announced that the company’s management team will participate at the Jefferies Healthcare Conference. Jefferies Healthcare ConferenceDate: Wednesday, June 7, 2023Location: Marriott Marquis, New… Continue reading Update — Reneo Pharmaceuticals to Participate at the Jefferies Healthcare Conference
